Joel Beatty - Robert W. Baird Analyst Performance This page shows the methodology used to calculate Joel Beatty's recommendation performance. Listed below are links to the research notes issued, the price targets issued by the analyst, and the stock's actual price 12 months from the date the research note was issued. These rankings are based on research reports from . Rankings are updated daily. MarketBeat Analyst Ranking: Subscribe to MarketBeat All Access for the recommendation accuracy ratingAverage 12-Month ROI of Buy and Strong Buy Recommendations: ???% Export to Excel CompanyReport DateReport Date Price12-MonthPrice TargetRating12-MonthActual Price12-MonthROIDetailsEDITEditas Medicine8/13/2025$2.29$6.00Outperform???%???%PTCTPTC Therapeutics8/8/2025$45.38$70.00???%???%COGTCogent Biosciences7/8/2025$9.35$9.00Neutral???%???%SAGESage Therapeutics6/20/2025$9.15$9.00Neutral???%???%ELFe.l.f. Beauty6/6/2025$118.65$145.00Outperform???%???%ACADACADIA Pharmaceuticals5/19/2025$21.76$31.00Outperform???%???%NGNENeurogene5/16/2025$19.37$24.00Neutral???%???%ELFe.l.f. Beauty5/14/2025$78.35$100.00Outperform???%???%EDITEditas Medicine5/13/2025$1.54$4.00Outperform???%???%DNTHDianthus Therapeutics5/13/2025$20.08$50.00Outperform???%???%ARGXargenex5/13/2025$560.90$680.00Outperform???%???%DNLIDenali Therapeutics5/8/2025$14.26$29.00Outperform???%???%PTCTPTC Therapeutics5/7/2025$40.26$66.00Outperform???%???%JAZZJazz Pharmaceuticals5/7/2025$102.22$155.00Outperform???%???%COGTCogent Biosciences5/7/2025$4.74$7.00Neutral???%???%AXSMAxsome Therapeutics5/6/2025$116.49$162.00Outperform???%???%ALKSAlkermes5/2/2025$30.58$41.00Outperform???%???%NGNENeurogene3/25/2025$8.20$38.00???%???%LRMRLarimar Therapeutics3/25/2025$2.28$10.00Outperform???%???%MNMDMind Medicine (MindMed)3/7/2025$6.61$16.00Outperform???%???%CTNMContineum Therapeutics3/7/2025$6.44$16.00Outperform???%???%ARGXargenex3/4/2025$631.50$680.00Neutral???%???%PRAXPraxis Precision Medicines3/3/2025$38.60$73.00Outperform???%???%CPRXCatalyst Pharmaceuticals3/3/2025$22.89$32.00Outperform???%???%AXSMAxsome Therapeutics3/3/2025$127.54$160.00Outperform???%???%COGTCogent Biosciences2/27/2025$6.71$8.00Neutral???%???%CPRXCatalyst Pharmaceuticals2/4/2025$22.62$28.00Outperform???%???%AXSMAxsome Therapeutics2/3/2025$137.75$132.00???%???%ICPTIntercept Pharmaceuticals6/30/2020$45.51$67.00Buy???%???%TPSTTempest Therapeutics5/29/2020$386.10$1,170.00Buy???%???%SNDXSyndax Pharmaceuticals5/22/2020$20.17$23.00Buy???%???%ICPTIntercept Pharmaceuticals5/12/2020$89.62$110.00Neutral???%???%AMRNAmarin5/1/2020$150.40$240.00Buy???%???%DBVTDBV Technologies4/6/2020$37.10$100.00Buy???%???%AMRNAmarin4/1/2020$80.00$120.00Buy???%???%NGMNGM Biopharmaceuticals3/27/2020$14.00$28.00Buy???%???%XFORX4 Pharmaceuticals3/26/2020$285.00$450.00Buy???%???%TPSTTempest Therapeutics3/24/2020$1,257.75$3,900.00Buy???%???%ICPTIntercept Pharmaceuticals2/26/2020$84.68$125.00Buy???%???%NGMNGM Biopharmaceuticals2/25/2020$18.87$34.00Buy???%???%PTCTPTC Therapeutics2/20/2020$59.36$71.00Neutral???%???%AMRNAmarin2/18/2020$352.40$480.00Buy???%???%ICPTIntercept Pharmaceuticals1/2/2020$123.92$140.00Neutral???%???%SRPTSarepta Therapeutics12/26/2019$129.77$177.00Buy???%???%MIRMMirum Pharmaceuticals12/17/2019$17.28$30.00Buy???%???%AMRNAmarin11/27/2019$20.59Neutral???%???%MDCOMedicines11/20/2019$69.59$59.00Hold???%???%PTCTPTC Therapeutics9/26/2019$33.82$62.00Buy???%???%LIFEaTyr Pharma8/30/2019$2.93$4.00Hold???%???%SLDBSolid Biosciences8/29/2019$136.35$90.00Sell???%???%VNDAVanda Pharmaceuticals8/1/2019$12.45$19.00Buy???%???%CBAYCymaBay Therapeutics6/13/2019$6.17$12.00Buy???%???%ESPREsperion Therapeutics5/28/2019$51.88$73.00Buy???%???%PHASPhaseBio Pharmaceuticals5/24/2019$10.52$27.00Buy???%???%SLDBSolid Biosciences5/16/2019$90.60$90.00Hold???%???%PTCTPTC Therapeutics5/3/2019$36.81$59.00Buy???%???%AMRNAmarin1/8/2019$279.20$400.00???%???%FGENFibroGen12/18/2018$987.50$1,775.00Buy???%???%PTCTPTC Therapeutics7/24/2018$39.46$50.00Buy???%???%NVAXNovavax3/1/2018$2.17Buy???%???%NVAXNovavax2/21/2018$48.40$55.00Neutral???%???%NVAXNovavax2/20/2018$46.80$60.00Hold???%???%ICPTIntercept Pharmaceuticals12/29/2017$62.71$74.00Hold???%???%ICPTIntercept Pharmaceuticals12/21/2017$62.85$74.00Hold???%???%NVAXNovavax12/19/2017$29.80$20.00Neutral???%???%XFORX4 Pharmaceuticals12/11/2017$4,191.00$8,100.00Buy???%???%ATXSAstria Therapeutics11/20/2017$97.20$180.00Buy???%???%KURAKura Oncology11/9/2017$13.85$19.00Buy???%???%NVAXNovavax10/31/2017$20.40$40.00Buy???%???%PTCTPTC Therapeutics9/27/2017$19.51$28.00Buy???%???%SNDXSyndax Pharmaceuticals8/11/2017$11.15$20.00Buy???%???%KURAKura Oncology8/8/2017$10.35$13.00Buy???%???%PTCTPTC Therapeutics7/20/2017$19.43$17.00Buy???%???%ESPREsperion Therapeutics6/22/2017$42.31Buy???%???%ESPREsperion Therapeutics3/21/2017$41.05$77.00???%???%ESPREsperion Therapeutics3/20/2017$41.05$39.00Buy???%???%ESPREsperion Therapeutics3/13/2017$31.10$39.00Buy???%???%ESPREsperion Therapeutics2/28/2017$25.87$39.00Buy???%???%HALOHalozyme Therapeutics1/6/2017$12.61Neutral???%???%HALOHalozyme Therapeutics1/5/2017$10.69$14.00Hold???%???%ESPREsperion Therapeutics11/14/2016$11.99Neutral???%???%KURAKura Oncology3/21/2016$4.34$12.00Buy???%???%RPTP(RPTP)1/26/2016$3.83Buy???%???%ESPREsperion Therapeutics10/2/2015$23.79$45.00Buy???%???%MDCOMedicines8/31/2015$33.64Hold???%???%NVAXNovavax7/9/2015$218.20$360.00Buy???%???%MDCOMedicines4/16/2015$29.12$32.00Hold???%???% Return to Analyst Rankings Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access